Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Inventory (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Inventory over the past 15 years, most recently at $32.3 million for Q2 2025.

  • Quarterly results put Inventory at $32.3 million for Q2 2025, down 19.23% from a year ago — trailing twelve months through May 2025 was $32.3 million (down 19.23% YoY), and the annual figure for FY2025 was $32.3 million, down 19.23%.
  • Inventory for Q2 2025 was $32.3 million at Lifecore Biomedical, Inc. \De\, down from $34.6 million in the prior quarter.
  • Over the last five years, Inventory for LFCR hit a ceiling of $42.0 million in Q1 2023 and a floor of $31.4 million in Q1 2021.
  • Median Inventory over the past 5 years was $38.8 million (2022), compared with a mean of $37.8 million.
  • Peak annual rise in Inventory hit 27.53% in 2021, while the deepest fall reached 53.11% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Inventory stood at $39.7 million in 2021, then dropped by 3.26% to $38.4 million in 2022, then grew by 7.88% to $41.4 million in 2023, then decreased by 5.39% to $39.2 million in 2024, then decreased by 17.65% to $32.3 million in 2025.
  • The last three reported values for Inventory were $32.3 million (Q2 2025), $34.6 million (Q1 2025), and $39.2 million (Q4 2024) per Business Quant data.